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Recent studies suggest that extrafollicular dermal melanocyte stem cells (MSCs) persist after birth in the superﬁcial nerve sheath
of peripheral nerves and give rise to migratory melanocyte precursors when replacements for epidermal melanocytes are needed
on the basal epidermal layer of the skin. If a damaged MSC or melanocyte precursor can be shown to be the primary origin of
melanoma,targetedidentiﬁcationanderadicationofitbyantibody-basedtherapieswillbethebestmethodtotreatmelanomaand
av eryeﬀectivewaytopreventitsrecurrence.TranscriptionfactorsandsignalingpathwaysinvolvedinMSCself-renewal,expansion
and diﬀerentiation are reviewed. A model is presented to show how the detrimental eﬀects of long-term UVA/UVB radiation on
DNA and repair mechanisms in MSCs convert them to melanoma stem cells. Zebraﬁsh have many advantages for investigating
the role of MSCs in the development of melanoma. The signaling pathways regulating the development of MSCs in zebraﬁsh are
very similar to those found in humans and mice. The ability to easily manipulate the MSC population makes zebraﬁsh an excellent
model for studying how damage to MSCs may lead to melanoma.
1.Introduction
Cutaneous malignant melanoma is the most serious form
of skin cancer with the highest mortality rate. The rate of
incidence for melanoma has been rising around the world
with the USA reporting about 60,000 cases and 8,000 deaths
every year [1]. It is a complex disease with multifaceted
etiology that involves both genetic and environmental fac-
tors. Most melanomas arise de novo, but some are known
to arise in preexisting nevi or moles [2]. Melanomagenesis
is often medically described as a gradual transformation of
a cutaneous melanocyte in the basal layer of the epidermis,
enabling the stepwise metamorphosis from nevus to radial-
growth phase, to vertical growth, and ﬁnally to metastatic
malignant melanoma [3].
The identity of the original target cell that acquires the
requisite DNA lesions for transformation to melanoma still
remains elusive. The traditional hypothesis is that cutaneous
melanocytes progressively accumulate mutations in onco-
genes and tumor suppressor genes over a long period of time
duringexposuretoUV,leadingtouncontrolledproliferation,
acquisition of invasive properties, and ability to metastasize
[4, 5]. An alternative hypothesis is that melanoma begins
in an extrafollicular dermal melanocte stem cell (MSC).
Although MSCs have not been deﬁnitively isolated, they are
likely to exist based on the presence of stem cell markers
on putative melanocyte precursors in the dermis [6]a n do n
multipotent stem cells in the dermis that have been isolated
and shown to diﬀerentiate into melanocytes in human skin
constructs[7–9].Understandingthemechanismscontrolling
self-renewal, expansion, and diﬀerentiation of the extrafol-
licular MSCs will provide greater insight into the possible
mechanisms for the neoplastic development of malignant
melanoma. UV-induced mutation may alter the normally
tightly controlled process of self-renewal, expansion, and
diﬀerentiation of MSCs as well as their exit from the stem
cell compartment. Diﬀerent forms of melanoma may reﬂect
the stage in the melanocytic diﬀerentiation pathway where
transformation occurs.
The purpose of this review is to summarize the data
supporting the existence of extrafollicular dermal MSCs
and to explain how the neoplastic development of malig-
nant melanoma is better understood when it is viewed as
having its earliest origins in an extrafollicular MSC or in2 Stem Cells International
a melanocyte precursor derived from it, rather than in a
mature, fully diﬀerentiated cutaneous melanocyte in the
basal layer of the epidermis [9–11].
2. Results andDiscussion
2.1. Epidermal Melanocytes. In humans melanocytes are
melanin-producing cells that comprise only about 5–10% of
all of the body’s skin cells. Each melanocyte is located on
the basal layer of the epidermis and immediately surrounded
by approximately ﬁve keratinocytes. Through multiple den-
driticextensions,melanocytesestablishcontactwithanaddi-
tional 35–40 keratinocytes to form an epidermal melanin
unit. The epidermal melanin unit is thought to be a sym-
biotic relationship between the melanocyte and the pool
of associated keratinocytes. The melanocyte maintains this
homeostatic ratio throughout its lifespan [12, 13]. When a
keratinocyte is exposed to sunlight, it relays signals to its
connecting melanocyte and turns on the pathways leading to
melanin synthesis and the formation of melanosomes. The
melanosomes are then transferred from the melanocytes to
the keratinocytes through the dendritic connections, col-
lectively forming a temporary microparasole over the skin.
Melanin serves to absorb UV photons and to quench highly
reactiveoxygenradicals,providingtheskinwithaﬁrstlineof
defense from the damaging rays of UV radiation [14].
Although melanocyte mitosis has been rarely observed
in vivo under normal physiological conditions, this is not
to suggest that melanocytes have lost their ability to divide.
A small percentage of melanocytes appear to divide during
normal skin homeostasis [15]. When melanocytes are sep-
arated from their normal physiological niche and cultured
in isolation, they divide continuously with doubling times
of 48–96hrs [16, 17]. The precise mechanisms that control
the organization and the number of melanocytes in the
epidermis are unknown. Several studies strongly suggest that
keratinocytes interact with melanocytes via growth factors,
cell surface molecules, or other factors related to prolifer-
ation and diﬀerentiation of the epidermis [18–20]. Con-
tinuous crosstalk between keratinocytes and melanocytes
is required to maintain a ratio of approximately 5:1 of
keratinocytestomelanocyteonthebasalepidermallayer[21,
22]. When melanocytes become transformed, they escape
the controlling inﬂuences of the surrounding keratinocytes
and develop new cellular connections with ﬁbroblasts and
endothelial cells to support their growth and invasion [23].
2.2. Evidence for Extrafollicular Dermal MSCs. Even though
extrafollicular dermal MSCs have not yet been isolated in
humanskin,itisplausiblethattheydoexistbasedonindirect
evidence of stem cell markers, tissue culture studies, and
repigmentation patterns observed in patients with vitiligo.
Althoughitisalwayspossiblethatexistingmelanocytescould
be stimulated to divide and to replace damaged melanocytes,
given the vital role that melanocytes play in constantly
protecting the skin against UV radiation, the skin is likely to
have a pool of MSCs in a well-protected area of the dermis to
draw upon to replace any damaged melanocytes in the basal
layer of the epidermis. The signal to replace a melanocyte
may originate from the surrounding keratinocytes that
comprise the epidermal melanin unit. Fully diﬀerentiated
melanocytes, like other cells of the skin, are constantly
exposed to solar UV. After a suﬃcient number of lesions, a
melanocyte that is damaged beyond the capability to repair
itself is likely to be eliminated via an apoptotic pathway.
Following apoptosis the homeostatic balance between the
melanocyte and surrounding keratinocytes will be disrupted
thus signaling a melanocyte stem cell in the dermis to
diﬀerentiate and migrate to the epidermis to reestablish the
melanocyte: keratinocyte ratio. For example, this may occur
after a severe sunburn or during body growth from child-
hood to adult stature to accommodate increased skin surface
area.
It was suggested many years ago that extrafollicular der-
mal melanocytes may be derived from pluripotent cells that
migrate from the neural crest to the skin via the paraspinal
ganglia and their peripheral nerves [24–26]. Here they give
rise to melanocyte precursors when replacements for epider-
mal melanocytes are needed in the postnatal skin [27]. Many
studies support the hypothesis that peripheral nerves may
function as a MSC niche from which cutaneous melanocytes
are recruited during skin regeneration and repair [28–32].
The most convincing evidence comes from the isolation of
human multipotent stem cells from the dermis of glabrous
skin that are capable of self-renewing and expressing the
neural crest stem cell markers NGFRp75 and nestin. When
these stem cells are placed in human skin reconstructs, they
migrate to the basal epidermis, establish communication
with keratinocytes, and diﬀerentiate into melanocytes [7, 9].
Other supporting evidence for extrafollicular MSCs in the
dermis comes from the observation that Schwann cells, the
principal glia of peripheral nerves, display a highly unstable
phenotypethatcanbereversedorinducedtotransdiﬀerenti-
ate while in culture, indicating that these cells, like stem cells,
are permissive for phenotypic changes [33].
The presence of MSC markers KIT and BCL-2 in the
basal layer of human epithelia suggests the presence of mel-
anocyte precursors [6]. Another possible marker of a MSC,
human CD133 antigen, has been found in stem cell niches
comprising the basal layer of human neonatal epidermis
[34]. Other evidence for dermal MSC comes from clinical
studies in patients with a skin disorder, vitiligo. Vitiligo is
an acquired disorder of pigmentation, characterized by
depigmented, cutaneous macules resulting from the loss of
functioning melanocytes. When a patient with vitiligo was
administered an oral dose of 8-methoxypsoralen in com-
bination with UVA therapy to stimulate repigmentation,
tyrosinase-positive melanocytes were detected along the
basement membrane in the previously depigmented palms.
This provides clinical evidence supporting the existence of a
MSC reservoir in glabrous skin [35, 36].
The evidence for the presence of extrafollicular dermal
MSCs in association with the peripheral nerves is derived
from a variety of vertebrates including quail, chicken and
zebraﬁsh, suggesting that the developmental pathways reg-
ulating MSCs are conserved and that the use of these animalStem Cells International 3
Table 1: Evidence for the presence of extrafollicular dermal MSCs
in human skin and in association with peripheral nerves of other
vertebrates.
Source Origin MSC marker Marker type
Human Dermis kit (+), trp-1(−),
bcl-2 (+)
Cytokine receptor,
tyrosinase apoptosis
regulator [6]
Human Dermis NGFRp75, Oct-4 Nerve growth factor
[7–9]
Quail Schwann
cells ETR-B Endothelin receptor
[29]
Chicken Spinal
ganglia Melanin Pigment [31]
Zebraﬁsh Dermis trp-1 (−) Tyrosinase [37–40]
Zebraﬁsh Nerve foxd3 and sox10 Transcription factors
[41]
models will likely yield important insights into the origin,
regulation and control of MSCs in humans (Table 1).
The presence of stem cell markers which are indicative of
cells in the melanocyte lineage, the isolation of multipotent
stem cells from the human dermis capable of diﬀerentiating
into melanocytes, and the capability of melanocytes to
regenerate provide substantial evidence that the vertebrate
dermis contains an extrafollicular reservoir of MSCs.
There is some evidence to suggest that the bulge region
of the hair follicle might serve as a supplemental reservoir
of MSCs to replenish melanocytes in the basal epidermal
layer of the skin [42]. This study is supported by the ﬁnding
that MSCs in the bulge region of the murine hair follicle
are capable of producing transient amplifying cells with the
potential to migrate into empty niches including the skin
[43].
2.3. Regulation of Extrafollicular Dermal MSCs. The mi-
crophthalmia-associated transcription factor (MITF) is the
master regulator of melanocyte diﬀerentiation, development
and survival [44]. It plays a central role in the complex
network of interacting genes regulating the migration,
survival and proliferation of melanocytes [45–47]. Because
of its crucial importance in regulating the development of
melanocytes, it is not surprising to ﬁnd that at diﬀerent
stages of melanocyte development, MITF expression is
regulated by an array of cooperating transcription factors
that all inﬂuence how the MITF promoter responds to
developmentalsignals[45].MITFisalsorequiredtoestablish
the MSC in the follicular niche [48, 49] and for this reason, it
is thought to play a role in regulating extrafollicular dermal
MSCs.
Two important transcription factors, PAX3 and SOX10,
areinvolvedintheregulationoftheMITFpromoterandthus
may also play critical roles in regulating the extrafollicular
MSCs [50–52]. Synergistically with SOX10, PAX3 strongly
activates MITF expression. These two transcription factors
physically interact and bind directly to the MITF promoter
[53, 54]. PAX3 is a member of a highly conserved family of
transcription factors essential during the early development
Table 2: Genes involved in the development of melanocytes in
humans, mice, and zebraﬁsh.
Gene Description Humans Mice Zebraﬁsh
MITF Transcription
factor [62, 63][ 64][ 65]
PAX3 Transcription
factor [66][ 67][ 68]
SOX10 Transcription
factor [50, 52][ 69][ 70]
Wnt Signaling protein [71][ 72][ 73]
Notch Membrane
protein [74, 75][ 76][ 77]
KIT Cytokine receptor [6, 78][ 79][ 5]
of many diﬀerent tissue types and to the preservation the
stem cell state. It aﬀects melanocyte proliferation, resistance
to apoptosis, migration, lineage speciﬁcity and diﬀerentia-
tion [55, 56]. This transcription factor functions as a nodal
point for coactivators and inhibitory proteins involved in
regulating the MSC, as well as its diﬀerentiation into a
mature melanocyte. Although the PAX3 protein is required
for melanocyte development during embryogenesis, it is not
found in normal mature melanocytes. PAX3 expression pre-
serves pluripotency and its repression induces diﬀerentiation
[57].
Wnt and Notch signaling pathways also play key roles in
regulating MSCs. WNT signaling regulates quiescence, ex-
pansion and diﬀerentiation of MSCs by modulating the
levelsofPAX3,SOX10andMITF[56–58].NOTCHsignaling
pathways are part of an evolutionary conserved complex of
signaling pathways and are essential for the maintenance
of the immature status of MSCs. In the hair follicles of
mouse skin, NOTCH signaling controls the spatial distri-
bution of MSCs and the timing of their diﬀerentiation into
melanocytes [59, 60]. These signaling pathways may be
equally important in regulating both quiescent (out of cell
cycle and in a lower metabolic state) and active (in cell cycle
and not able to retain DNA labels) MSC subpopulations that
may coexist in the dermis in separate yet adjoining locations
[61].
Genes regulating the development of MSCs are highly
conserved in humans, zebraﬁsh and mice, providing con-
ﬁdence that experimental ﬁndings involving MSCs in
zebraﬁsh can be translated to humans for understanding the
origins of melanoma (Table 2).
2.4. Melanoma Begins in an Extrafollicular Dermal MSC.
Solar ultraviolet (UV) radiation is the prominent environ-
mental physical carcinogen involved in melanoma. Decades
of epidemiologic studies link solar UV radiation to the
development of malignant melanoma [80]. Solar UV reach-
ing Earth’s surface is a continuum of electromagnetic
radiation and is divided into UVA (320–400nm) and UVB
(290–320nm) wavelengths for purposes of describing the
biological eﬀects associated with long- and short-wave UV
radiation. The speciﬁc contribution of UVA and UVB in
the etiology of melanoma is controversial. However, there4 Stem Cells International
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Figure 1: A model summarizing how important signalling pathways, and some DNA repair and transcription factors in melanocyte and
keratinocyte stem cells or in their derivatives, might be impaired by UV irradiation, leading to the development of melanoma stem cells.
Lower levels of the repair enzyme, human 8-oxoguanine-DNA glycosylase (OGGI), UV-damaged DNA-binding protein (UV-DDB), along
with an attenuated p53 apoptotic response will increase survival of cells in the melanocyte lineage with mutational loads and genetic
instability (GI). Increased expression of Nrf2 will further prevent UVA-induced apoptosis and thus promote survival of cells, increasing the
retention and accumulation of mutations. Mutations in critical genes for transcription factors regulating melanocyte stem cell proliferation
and diﬀerentiation (MITF, PAX3 and SOX10) or in signaling pathways (Notch and Wnt) will have profound and cascading eﬀects on those
pathways regulating the quiescence, expansion and diﬀerentiation of melanocyte stem cells. Increased β-catenin stimulate proliferation,
abnormal diﬀerentiation, and self-renewal of melanocyte stem cells. Alterations in c-kit tyrosine kinase receptor (KIT) and its ligand, (stem
cell factor (SCF)), will alter the homeostatic balance between keratinocytes and melanocytes. All of these factors may interact and contribute
to the transformation of an epidermal MSC into a melanoma stem cell.
is adequate evidence to suggest that both UVA and UVB
radiation act together and sometimes synergistically to
promote the development and progression of malignant
melanoma [81]. UVB radiation is less penetrating and is
directly absorbed by DNA, causing several mutagenic DNA
lesions; UVA radiation on the other hand, penetrates deeper
in the skin and indirectly produces its eﬀects by the gener-
ation of reactive oxygen species (ROS), leading to oxidative
damage of DNA and protein [82]. That fact that ROS is
implicated in all stages of multisteps carcinogenesis suggests
that UVA may play an important role in the development of
melanoma [83]. However, the relative roles of UVA and UVB
radiationinthedevelopmentofmelanomaarefarfrombeing
resolved. One of the most important factors in the cellular
ROS defense machinery is the transcription factor Nrf2.
It induces the production of a variety of ROS detoxifying
enzymes and antioxidants such as glutathione and plays an
important role in the protection of the skin against UVA-
induced apoptosis [84]. Nrf2-mediated ROS cytoprotection
isalsothoughttobepartiallyresponsiblefordecreasedUVB-
induced apoptosis in the skin [85, 86]. We speculate that
this increased level of protection against apoptosis via Nrf2
may be a double-edged sword. By decreasing apoptosis of
damaged cells after exposure to intense and intermittent UV
radiation of tanning beds, it may well promote the retention
and accumulation of UV-induced damage in quiescent and
active MSCs in the dermis.
Our proposed model (Figure 1) for the origin of malig-
nant melanoma is based on the hypothesis that cutaneous
melanoma has its earliest origins in an extrafollicular MSC
residing in the dermis of the skin. Under normal environ-
mental conditions, cellular DNA in the MSC will be fre-
quently exposed to various doses and ﬂuence rates of UVA
and UVB radiation from sunlight, and in some cases, from
exposure to high ﬂuences delivered by tanning beds. UVA
radiation because of its longer wavelength will penetrate
deeper into the dermal layer of the skin than the shorter
UVB wavelengths [87]. Therefore, our model places greaterStem Cells International 5
emphasis on the eﬀects of UVA radiation on dermal MSCs in
the beginning stages of melanoma. UVA has the potential to
inﬂict DNA damage to the MSC residing in the superﬁcial
nerve sheath of peripheral nerves. This scenario is similar
to what is found in squamous cell carcinomas where
UVA ﬁngerprint mutations are most abundant in the basal
germinative layer, suggesting that UVA- rather than UVB-
induced DNA damage is an important carcinogen in the
stem cell compartment of the skin [88]. Damage to DNA
and repair proteins in MSCs will occur via the production
ROS, hydrogen peroxide, and superoxide anion [89]. ROS
may also give rise to the very reactive hydroxyl radical via
Fentonreactionswhenferritin,whichisknowntorestrictthe
availability of iron after UVA irradiation, is impaired or fails
to be induced [90, 91]. Short-term exposure to high ﬂuences
of UVA in tanning beds provokes an immediate increase in
intracellularlabileironbeforedefensemechanismshavetime
to remove the iron. This provides an ideal environment for
generating oxidative reactions leading to increased damage
to DNA and proteins [92]. An important repair enzyme,
human 8-oxoguanine-DNA glycosylase (OGG1), known
to be involved in repairing UVA-induced oxidative DNA
damage, is much lower in skin cells of the basal layer of the
human epidermis including melanocytes [93]. This suggests
that oxidative DNA mutations may also be less eﬃciently
repaired in MSCs. A study showing that epidermal stem
and progenitor cells in murine epidermis are prone to the
accumulation of cyclobutane pyrimidine dimers (CPDs)
despitenucleotideexcisionrepair(NER)proﬁciencysuggests
that human MSC will also accumulate more DNA damage
in the form of CPDs during chronic UV irradiation [94,
95]. UVA irradiation has been shown to promote a greater
number of oxidative DNA lesions in melanocytes than in
keratinocytes, supporting the role that UVA may play in
promoting DNA damage in cells of the melanocyte lineage
including MSCs or melanocyte precursors [96].
Our extrafollicular dermal MSC model for the origin of
melanoma predicts that any MSC residing in the dermis will
accumulate DNA damage over the lifetime of an individual
when protective and repair mechanisms are impaired due
to the cumulative eﬀects of UVA exposure from the sun or
artiﬁcial sources such as tanning beds. Emerging evidence
indicates that both quiescent (out of cell cycle and in a lower
metabolicstate)andactive(incellcycleandnotabletoretain
DNA labels) stem cell subpopulations may coexist in several
tissues in separate yet adjoining locations [61]. This may
provide opportunities for MSCs to accumulate mutations
when repair mechanisms are impaired. Severe sunburn in
early childhood poses a signiﬁcant risk for the development
of melanoma well into adulthood [97, 98]. Damage to repair
pathways will make MSCs more susceptible to subsequent
radiation.Whenthisoccursearlierinlife,theMSCswillhave
a longer period of time to accumulate additional mutations
[10]. Through the years,if they evade DNA repair and escape
apoptosis due to defects in ROS defense mechanisms and
damage response signaling pathways, MSCs will progres-
sively accumulate genetic and epigenetic changes in their
genome. We speculate that over time the dermal MSCs in
diﬀerent areas of the skin will accumulate a vast array of
mutations due to exposure to diﬀerent intensities of UVA
from natural and artiﬁcial sources.
The importance of DNA repair in preventing the devel-
opment of melanoma is illustrated in patients with xero-
derma pigmentosum that have a defect in the nucleotide
excision repair gene XPA and develop tumors with a high
frequency on sun-exposed areas of the skin [99]. This sug-
gests that DNA repair capacity plays an important role in
preventing MSCs from accumulating UVA-induced DNA
lesions that will tend to make any adult melanocyte devel-
opmentally derived from them to be more vulnerable to
subsequent UVB-radiation when they migrate to the basal
layer of the epidermis. Early onset of tumors and malignancy
due to unrepaired DNA lesions, mutations or chromosomal
modiﬁcations will then occur more often in sun-exposed
areas of the skin.
MSCs ensure that adequate numbers of melanocytes are
maintained so that keratinocytes receive enough melanin to
protect the skin against the damaging rays of the sun. They
regenerate melanocytes in response to damage and replace
senescent melanocytes that no longer function. Age related
loss of DNA damage repair pathways, through accumulated
mutations from increased oxidative stress imposed by UV
radiation, poses a signiﬁcant threat to stem cell survival and
function. Normal MSCs have strict control of gene expres-
sion and DNA replication whereas MSCs with loss of DNA
repair may have altered patterns of proliferation, quiescence,
and diﬀerentiation. Aging MSCs with loss of DNA repair
may be more susceptible to malignant transformation upon
subsequent exposure to intermittent UV [100]. Activation
of DNA repair involves the participation of p53 [101]. Hair
graying is a visible manifestation of aging MSCs and loss of
self-renewal in the niche [102]. Thus, it is quite reasonable
to suspect that the extrafollicular dermal MSC population
in the skin is susceptible to UV-induced breakdown of DNA
repair, bringing about increased genomic instability in these
cells over time.
Mutated MSCs within the nerve sheath of peripheral
nerves associated with skin may remain quiescent for years
before they are called upon to replace severely damaged
cutaneous melanocytes eliminated through apoptosis. How
long the mutated MSCs remain quiescent will depend on the
need of the skin to replace damaged cutaneous melanocytes.
The extent of damage will depend on the nature and extent
of UV radiation received by any given area of the skin over
a certain period of time. For example, the intensity and
frequency of both natural and artiﬁcial doses of UVA/UVB
radiation experienced due to the lifestyles of any one
individual, will certainly aﬀect the lifespan of an epidermal
melanocyte and thus how often the skin will need to signal a
MSC to provide an replacement.
T h ed u r a t i o na sw e l la st h ep r e c i s es t a g e so fd i ﬀeren-
tiation that a melanocyte precursor will go through as it
migrates to a permanent residence on the basal layer of the
epidermis is largely unknown. It may take several months
o rm o r et oc o m p l e t ea l lf o u rs t a g e so fm e l a n o c y t ed i ﬀer-
entiation starting from the MSC (nerve-sheath precursor
stage) and proceeding through the dermal and junctional
migratory stages ending with the dendritic stage on the basal6 Stem Cells International
layer of the epidermis [24]. It is likely that transformation
of an MSC itself or of a precursor during any of the stages
leading up to a fully diﬀerentiated melanocyte will involve
disruption of the normally tightly controlled process of self-
renewal, stem cell expansion, diﬀerentiation and migration.
Any factors which disrupt the normal physiology of the
niche may trigger cascading eﬀects and disrupt the normal
homeostatic mechanisms regulating MSCs. Many of the
signaling pathways regulating the regeneration of organ and
tissues from stem cells overlap with those involved in
pathways leading to carcinogenesis. This is consistent with
the hypothesis that the earliest origins of melanoma begin in
an extrafollicular dermal MSC when its molecular pathways
regulating cell-cycle status are altered, leading to uncon-
trolled proliferation and abnormal diﬀerentiation [103].
Our model for the development of melanoma is based
on the premise that a melanocyte precursor will be more
vulnerable to UV-induced lesions than a fully diﬀerentiated
melanocyte as it progresses through the diﬀerent stages of
maturation before reaching permanent residence on the
basal layer of the epidermis. As a dermal MSC enters the
melanocyticdiﬀerentiationpathwayandbeginsitsmigration
to the epidermis to establish contact with the surrounding
keratinocytes, it will gradually become more exposed to the
less penetrating but more energetic UVB rays of sunlight.
UVB radiation is directly absorbed by DNA and indirectly
damages proteins and lipids by the formation of ROS.
UVB-induced DNA modiﬁcations can lead to deleterious
mutations, while oxidation of proteins and lipids may impair
cell signaling pathways [85]. This continuum of possible
targetcellsinthelayersoftheskin,createdbytheexistenceof
melanocyte precursors at all stages along the diﬀerentiation
pathway, may explain the diﬀerent degrees of malignancy
commonly seen in melanoma in diﬀerent areas of the skin
[104]. For example, aggressive forms of melanoma may
reﬂect carcinogenic action in melanocyte precursors that
were in the more primitive stages of the diﬀerentiation path-
way [105]. Melanocyte precursors that have accumulated
more mutations in critical repair and defense pathways but
not yet transformed will have a higher probability of being
transformed at later stages when they experience additional
UV radiation from natural or artiﬁcial sources during their
journey to the basal layer of the epidermis. Some mel-
anocytes may reach the epidermis but will have compro-
mised genomes, signaling proteins and antioxidant pathways
making them more susceptible to transformation when ex-
posed to high ﬂuences of UVA/UVB irradiation.
Keratinocyte-derived growth factors and molecular
crosstalk mediated by E-cadherin are likely to play a major
role in regulating the activation and proliferation of abnor-
mal melanocyte precursors immediately derived from ex-
trafollicular dermal MSCs. Mutations in any of the genes
regulating growth factors or crosstalk pathways may con-
tribute to the transformation of a MSC at any stage of
diﬀerentiation. The β-catenin gene is a likely candidate since
it is generally involved in the self-renewal of stem cells
and mutations of this gene have been found in patients
withmelanoma[106].β-catenindissociatesfromE-cadherin
at the epithelial membrane and translocates to the nucleus
where it activates transcription of WNT target genes [107].
Impaired β-catenin signaling is known to be linked to in-
creasedproliferation,abnormaldiﬀerentiationandincreased
self-renewalofMSCs[108].IncreasingthefrequencyofMSC
renewal will provide greater opportunities for accumulated
DNA lesions to be converted to mutations in apoptotic and
cell-cycle pathways, increasing the probability that either the
MSC or its immediate melanocyte precursor will have a
greater chance to transform into a melanoma stem cell.
2.5. Melanocyte Stem Cells in the Zebraﬁsh. The zebraﬁsh is
becoming an ideal vertebrate system to study the interplay
of those variables known to play a role in the development
of melanoma. The melanocyte is common to both zebraﬁsh
andhumans.Awealthofzebraﬁshpigmentationmutantsare
available that aﬀect melanocyte speciﬁcation, diﬀerentiation
and function. Many of these genes have conserved roles in
mammalsandarenearlyidenticaltohumans[109].Fishskin
biology has major relevance to mammalian skin and oﬀers
a convenient animal model to gain molecular insights into
regeneration and regulation of MSCs [110].
Our laboratory is currently utilizing the zebraﬁsh model
toinvestigatetheeﬀectsofUVB/UVAradiationonMSCs.We
are taking advantage of the recent discovery that the copper
chelator, neocuproine (NCP), ablates adult melanocytes
but not MSCs in the zebraﬁsh. Following NCP washout,
melanocytes regenerate from MSCs [38]. This is providing
us with a very power technique to control the development
of the entire melanocyte population in the zebraﬁsh and
synchronize their regeneration. Using this drug we can
irradiate the entire stem cell population at one time. The
drug-induced ablation of melanocytes can be done multiple
times, permitting us to study how repeated rounds of UVA/
UVB irradiation of MSCs aﬀect the development of
melanoma.
The regeneration of the adult zebraﬁsh caudal ﬁn is
oﬀering another opportunity to determine the eﬀects of
UVA/UVB irradiation on MSCs. Melanocytes in the regen-
erated ﬁn arise from MSCs rather than from migration of
previously diﬀerentiated melanocytes [111]. Furthermore,
ontogenetic and regeneration melanocytes not only come
from the same MSCs that colonize the ﬁn, but also from the
same MSCs responsible for growth and maintenance of the
melanocyte pattern [112]. Studies of single progenitors or
MSCs reveal no transfating or transdiﬀerentiation between
other lineages in the regenerating ﬁn, showing that MSCs
retain fate restriction when passed through the blastema
[113]. This assuresusthat anydamageto melanocytepattern
or proliferation that persists after additional amputations
will be due to permanent genetic lesions in one or more
MSCs. We stop the division and progression of melanocyte
precursors from MSCs at diﬀerent stages after amputation
of the ﬁn by using small-molecule inhibitors to achieve
transient, reversible suppression of Wnt/β-catenin pathway
[114,115].Thus,wehavethecapabilitytostudytheeﬀectsof
UV irradiation on synchronized populations of melanocyte
precursors at diﬀerent stages of diﬀerentiation leading to a
mature melanocyte. This is helping us to determine speciﬁcStem Cells International 7
stagesofincreasedsensitivitytoUVandhowincreasedUVat
any one stage contributes to the development of melanoma.
3. Conclusion
Identifying the cell of origin for melanoma has a direct
bearing on prognosis and chemoprevention strategies for
melanoma. If melanoma has its origins in a MSC or in one
of the melanocyte precursor stages that eventually leads to a
fully diﬀerentiated melanocyte on the basal layer of the epi-
dermis,itwillbefarbettertotargetthepathwaysinthesecells
tokeepself-renewalincheck[116].Identifyingthemolecular
pathways and signaling molecules involved in MSC self-
renewal and how these pathways are dysregulated by solar
UV to produce a melanoma stem cell will be important
for the development of more eﬀective drugs for melanoma
prevention and intervention [117]. If a damaged MSC or
one of its precursors can be shown to be the cellular origin
of melanoma, targeted identiﬁcation and eradication by
antibody-based therapies will be the best method to treat
melanoma and a very eﬀective way to prevent its recurrence
[118]. The zebraﬁsh model oﬀers some powerful methods
for investigating the role of MSCs in the development of
melanoma.
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